Test Price
2,800 AED✅ Home Collection Available
DDB2 Gene Xeroderma Pigmentosum Group E Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited NGS processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Complimentary telephonic post-test clinical interpretation of your DNA results.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Turnaround Time: 3–4 Weeks from sample receipt.
Test Overview & Methodology
The DDB2 Gene Genetic Test is essential for early diagnosis, family screening, and personalized prevention in the UAE’s high-ultraviolet environment. This Next Generation Sequencing assay provides complete coverage of the DDB2 gene to identify pathogenic variants associated with Xeroderma Pigmentosum Group E.
| Feature | Our NGS Test (2800 AED) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next Generation Sequencing (full gene coverage, 99.9% sensitivity) | Targeted exon sequencing (limited coverage) |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Regulatory Alignment | DHA/MOHAP Standards, ISO 9001:2015 | No ISO accreditation, regional lab variance |
| Clinical Support | Post-test genetic counselling via phone | Limited or paid counselling |
Physician Insight & Safety Protocols
"A molecular diagnosis of Xeroderma Pigmentosum Group E through DDB2 gene sequencing provides a critical roadmap for UV avoidance, regular dermatological surveillance, and early intervention. Always integrate these genomic findings with a comprehensive clinical history and ophthalmologic assessment."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA No. 9294403)
Clinical Advisory
Important Clinical Guidance
Do not alter any prescribed UV protection regimen, medication, or medical follow-up based solely on this genetic result. The test informs clinical management but does not replace ongoing care from your treating physician. Always consult your specialist before making any changes.
Exclusion Criteria & Safety Red Flags
Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients with acute psychiatric crises or inability to provide informed consent without a legal guardian (as per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Exclusion: Sample contamination or insufficient DNA yield; a recollection may be requested.
- Seek Emergency Care if: You develop widespread blistering burns, bleeding skin nodules, sudden neurological symptoms (seizures, ataxia), or intense eye pain/photophobia after minimal UV exposure.
Patient FAQ & Clinical Guidance
1. What exactly does this DDB2 gene test reveal?
This NGS test analyzes your DDB2 gene to identify mutations causing Xeroderma Pigmentosum Group E. It distinguishes pathogenic variants from benign polymorphisms, enabling a definitive molecular diagnosis. Clinicians use this to confirm XP-E, assess cancer predisposition, and guide strict photoprotection.
2. How should I prepare and how is the sample collected?
Simply provide a small blood sample (1 drop on an FTA card or 3 mL whole blood) during a home visit. No fasting is required. Our VIP phlebotomist arrives with a cold-chain kit, collects the sample in minutes, and transports it to our ISO-certified genetics lab. You must have a prior genetic counselling session to document family history; we can facilitate this remotely if needed.
3. Who needs this test? Is it only for children with symptoms?
This is for anyone with unexplained photosensitivity, early‑onset skin cancers, or a family history of XP. Adults exploring unexplained skin fragility, couples planning a pregnancy (carrier screening), and athletes in intense UV environments may also benefit. A referral from a dermatologist, oncologist, or sports medicine specialist is recommended to contextualize results.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance
This service adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and medical liability align with Federal Decree-Law No. 4 of 2016 on Medical Liability. All processing is performed at our DHA-licensed facility (No. 1143) under ISO 9001:2015 certification.
Clinical & Logistical Metadata
| Test Name | DDB2 Gene Xeroderma Pigmentosum Group E Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (FTA card or 3 mL EDTA tube) |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | Q82.1 (Xeroderma pigmentosum) |
| LOINC Code | 96515-6 (Genetic testing for xeroderma pigmentosum) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians